Paper28299619
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
Ryu T and 6 others. J Gastrointest Surg, 2017. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A. Papers, record 28299619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28299619
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Hepatectomy | Major topic |
| Liver Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Biomarkers | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Plant Lectins | |
| Prognosis | |
| Protein Precursors | |
| Prothrombin | |
| Retrospective Studies | |
| Survival Analysis | |
| alpha-Fetoproteins |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21606837 | Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival. | Ann Surg | 2011 | https://conductscience.org/library/papers/21606837 | PubMed |
| 2 | 11169939 | Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. | Cancer | 2001 | https://conductscience.org/library/papers/11169939 | PubMed |
| 3 | 9794907 | Early hepatocellular carcinoma as an entity with a high rate of surgical cure. | Hepatology | 1998 | https://conductscience.org/library/papers/9794907 | PubMed |
| 4 | 15690326 | Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. | Cancer | 2005 | https://conductscience.org/library/papers/15690326 | PubMed |
| 5 | 16542289 | Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? | Am J Gastroenterol | 2006 | https://conductscience.org/library/papers/16542289 | PubMed |
| 6 | 20711614 | Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. | J Gastroenterol | 2011 | https://conductscience.org/library/papers/20711614 | PubMed |
| 7 | 18087193 | Microwave ablation of hepatocellular carcinoma. | Oncology | 2007 | https://conductscience.org/library/papers/18087193 | PubMed |
| 8 | 16431313 | Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16431313 | PubMed |
| 9 | 19259739 | Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. | Ann Surg Oncol | 2009 | https://conductscience.org/library/papers/19259739 | PubMed |
| 10 | 16682732 | Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16682732 | PubMed |
| 11 | 9927159 | Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. | J Hepatol | 1999 | https://conductscience.org/library/papers/9927159 | PubMed |
| 12 | 27577937 | Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism. | Surg Today | 2017 | https://conductscience.org/library/papers/27577937 | PubMed |
| 13 | 26955286 | Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/26955286 | PubMed |
| 14 | 10898182 | Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. | J Am Coll Surg | 2000 | https://conductscience.org/library/papers/10898182 | PubMed |
| 15 | 8983610 | Recurrence of hepatocellular carcinoma after surgery. | Br J Surg | 1996 | https://conductscience.org/library/papers/8983610 | PubMed |
| 16 | 24245496 | Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinoma. | Hepatol Res | 2014 | https://conductscience.org/library/papers/24245496 | PubMed |
| 17 | 4541913 | Transection of the oesophagus for bleeding oesophageal varices. | Br J Surg | 1973 | https://conductscience.org/library/papers/4541913 | PubMed |
| 18 | 21278701 | The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area. | Med Sci Monit | 2011 | https://conductscience.org/library/papers/21278701 | PubMed |
| 19 | 20582515 | Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria. | Surg Today | 2010 | https://conductscience.org/library/papers/20582515 | PubMed |
| 20 | 8546582 | Results of 280 liver resections for hepatocellular carcinoma. | Arch Surg | 1996 | https://conductscience.org/library/papers/8546582 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41249657 | Improving surgical treatments for hepatocellular carcinoma. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41249657 | PubMed |
| 39330520 | Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. | Metabolites | 2024 | https://conductscience.org/library/papers/39330520 | PubMed |
| 38149643 | Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis. | Health Technol Assess | 2023 | https://conductscience.org/library/papers/38149643 | PubMed |
| 37686624 | Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686624 | PubMed |
| 35271670 | Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma. | PLoS One | 2022 | https://conductscience.org/library/papers/35271670 | PubMed |
| 34638251 | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638251 | PubMed |
| 34506026 | Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative. | J Gastrointest Surg | 2022 | https://conductscience.org/library/papers/34506026 | PubMed |
| 34488769 | Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34488769 | PubMed |
| 34377560 | The Role of the MCTS1 and DENR Proteins in Regulating the Mechanisms Associated with Malignant Cell Transformation. | Acta Naturae | 2021 | https://conductscience.org/library/papers/34377560 | PubMed |
| 33531992 | A Practical Model is Equivalent to the BALAD or BALAD-2 Score in Predicting Long-term Survival after Hepatectomy in Chinese Patients with Hepatocellular Carcinoma. | J Cancer | 2021 | https://conductscience.org/library/papers/33531992 | PubMed |
| 32998218 | Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32998218 | PubMed |
| 31541423 | APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. | Hepatol Int | 2019 | https://conductscience.org/library/papers/31541423 | PubMed |
| 31231700 | Transplantation versus liver resection in patients with hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31231700 | PubMed |
| 30788712 | A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. | J Gastrointest Surg | 2019 | https://conductscience.org/library/papers/30788712 | PubMed |
| 30655749 | High expression of density-regulated re-initiation and release factor drives tumourigenesis and affects clinical outcome. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30655749 | PubMed |
| 29736665 | Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade. | J Gastrointest Surg | 2018 | https://conductscience.org/library/papers/29736665 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28299619
GET https://conductscience.org/api/papers/v1/28299619/references?page=2